These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19557207)

  • 1. Montelukast as an alternative to low-dose inhaled corticosteroids in the management of mild asthma (the SIMPLE trial): an open-label effectiveness trial.
    McIvor RA; Kaplan A; Koch C; Sampalis JS
    Can Respir J; 2009; 16 Suppl A(Suppl A):11A-21A. PubMed ID: 19557207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial).
    Keith PK; Koch C; Djandji M; Bouchard J; Psaradellis E; Sampalis JS; Schellenberg RR; McIvor RA
    Can Respir J; 2009; 16 Suppl A(Suppl A):17A-31A. PubMed ID: 19557208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast as add-on therapy to inhaled corticosteroids in the management of asthma (the SAS trial).
    FitzGerald JM; Foucart S; Coyle S; Sampalis J; Haine D; Psaradellis E; McIvor RA
    Can Respir J; 2009; 16 Suppl A(Suppl A):5A-14A. PubMed ID: 19557206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review.
    Joos S; Miksch A; Szecsenyi J; Wieseler B; Grouven U; Kaiser T; Schneider A
    Thorax; 2008 May; 63(5):453-62. PubMed ID: 18443162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study.
    Virchow JC; Mehta A; Ljungblad L; Mitfessel H;
    Respir Med; 2010 May; 104(5):644-51. PubMed ID: 20031382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma.
    Price DB; Hernandez D; Magyar P; Fiterman J; Beeh KM; James IG; Konstantopoulos S; Rojas R; van Noord JA; Pons M; Gilles L; Leff JA;
    Thorax; 2003 Mar; 58(3):211-6. PubMed ID: 12612295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors.
    Ducharme FM; Noya FJ; Allen-Ramey FC; Maiese EM; Gingras J; Blais L
    Curr Med Res Opin; 2012 Jan; 28(1):111-9. PubMed ID: 22077107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory markers as exacerbation risk factors after asthma therapy switch from inhaled steroids to montelukast.
    Ciółkowski J; Mazurek H; Hydzik P; Stasiowska B
    Pulm Pharmacol Ther; 2016 Aug; 39():7-13. PubMed ID: 27234706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma.
    Szefler SJ; Carlsson LG; Uryniak T; Baker JW
    J Allergy Clin Immunol Pract; 2013 Jan; 1(1):58-64. PubMed ID: 24229823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of parental preference for the treatment of asthmatic children aged 6 to 11 years with oral montelukast or inhaled cromolyn: a randomized, open-label, crossover study.
    Bukstein DA; Bratton DL; Firriolo KM; Estojak J; Bird SR; Hustad CM; Edelman JM
    J Asthma; 2003; 40(5):475-85. PubMed ID: 14529097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do children with stable asthma benefit from addition of montelukast to inhaled corticosteroids: randomized, placebo controlled trial.
    Stelmach I; Ożarek-Hanc A; Zaczeniuk M; Stelmach W; Smejda K; Majak P; Jerzynska J; Anna J
    Pulm Pharmacol Ther; 2015 Apr; 31():42-8. PubMed ID: 25640020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study.
    Korn D; Van den Brande P; Potvin E; Dramaix M; Herbots E; Peché R
    Curr Med Res Opin; 2009 Feb; 25(2):489-97. PubMed ID: 19192994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
    Rand C; Bilderback A; Schiller K; Edelman JM; Hustad CM; Zeiger RS;
    J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and tolerability of inhaled montelukast plus inhaled mometasone compared with mometasone alone in patients with chronic asthma.
    Philip G; Villarán C; Shah SR; Vandormael K; Smugar SS; Reiss TF
    J Asthma; 2011 Jun; 48(5):495-502. PubMed ID: 21545249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children.
    Ghiro L; Zanconato S; Rampon O; Piovan V; Pasquale MF; Baraldi E
    Eur Respir J; 2002 Sep; 20(3):630-4. PubMed ID: 12358339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
    Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
    Nelson HS; Busse WW; Kerwin E; Church N; Emmett A; Rickard K; Knobil K
    J Allergy Clin Immunol; 2000 Dec; 106(6):1088-95. PubMed ID: 11112891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.